Matthew Moreno – Trademark Portfolio

Entity Type: 01

Matthew Moreno holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 20 (Furniture) — 1 filings in this category. The portfolio also extends into Class 16 (Paper Goods) across 3 Nice Classification classes. Currently, 1 trademark is registered and 1 is pending. Notable registered marks include ELEPHANT DREAMS. The owner is based in Sarasota, FL.

3501 Riviera Drive

Sarasota, FL 34232

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Matthew Moreno's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

20
Furniture (1 filing)

Furniture, mirrors, picture frames; goods of wood, cork, reed, cane, wicker

16
Paper Goods (1 filing)

Paper and cardboard; printed matter; bookbinding material; photographs; stationery

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Matthew Moreno have?

Matthew Moreno has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 pending.

What trademark classes does Matthew Moreno file in?

Matthew Moreno files trademarks across 3 Nice Classification classes. The most active classes are Class 20 (Furniture), Class 16 (Paper Goods), Class 5 (Pharmaceuticals). Class 20 covers furniture, mirrors, picture frames; goods of wood, cork, reed, cane, wicker.

What are Matthew Moreno's most well-known trademarks?

Matthew Moreno's registered trademark portfolio includes well-known marks such as ELEPHANT DREAMS. These are among 1 currently registered trademark in the portfolio.

What is Matthew Moreno's trademark registration success rate?

Matthew Moreno has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 1 application is pending review.